Latest Breaking News On - Disease assessment scale - Page 1 : comparemela.com

Lifestyle Intervention Can Improve Cognition, Function in Early Alzheimer Disease

Can lifestyles changes reduce Alzheimer's risk?

Alzheimer's Slowed by Intensive Lifestyle Changes

Small trial led by Dean Ornish, MD, shows cognitive improvement

BioVie Announces Pipeline Update and Near-Term Clinical Priorities

Recently completed financing provides sufficient funds for near-term Parkinson’s Disease priority Plans for Phase 2b trial of NE3107 as first-line monotherapy for Parkinson’s Disease being finalized with targeted launch late-summer 2024 Once-daily NE3107 formulation expected to be available early 2025 and will be used for Phase 3 trial in Alzheimer’s Disease Phase 3 trial for BIV201 in preparation following FDA feedback with guidance on development path; program delayed pending partnership fundi

Monoclonal Antibodies May Cause Serious Harm for Patients with Alzheimer

Myloid-reducing monoclonal antibodies for patients with Alzheimer have harmful risks, such as cerebral edema, hemorrhage, serious adverse events, and death, according to a new study.